title: Improving type 1 diabetes after treatment of immune thrombocytopenia with rituximab: killing two birds with one stone.
authors.forename: Laura
authors.initials: L
authors.lastname: Quintana
authors.forename: Juan A
authors.initials: JA
authors.lastname: Paniagua
authors.forename: Daniel
authors.initials: D
authors.lastname: Gil-Contreras
authors.forename: Victor
authors.initials: V
authors.lastname: Jimenez-Yuste
authors.forename: Antonio
authors.initials: A
authors.lastname: Torres
authors.forename: Francisco
authors.initials: F
authors.lastname: Velasco
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D000069283:Rituximab; D013921:Thrombocytopenia / Q000188:drug therapy*; D055815:Young Adult
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab